Abvc Biopharma (ABVC) Shares Issued (2018 - 2019)
Abvc Biopharma's (ABVC) quarterly Shares Issued came in at $428571.0 in Q2 2019, down 98.96% quarter-over-quarter from $41.2 million in Q4 2018.
Powered by 
Analysis
Abvc Biopharma (ABVC) Shares Issued (2018 - 2019) Analysis & Trends
Abvc Biopharma (ABVC) has reported Shares Issued for 2 consecutive years, with $428571.0 the latest figure, recorded in Q2 2019.
- For the quarter ending Q2 2019, Shares Issued changed N/A year-over-year to $428571.0; the trailing twelve-month figure through Jun 2019 stood at $428571.0 (changed N/A YoY), and the FY2018 full-year result was $41.2 million, changed N/A from the prior year.
- Shares Issued declined to $428571.0 in Q2 2019 per ABVC's latest filing, from $41.2 million in the prior quarter.
- Across five years, Shares Issued topped out at $41.2 million in Q4 2018 and bottomed at $428571.0 in Q2 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Abvc Biopharma | 25.56 Mn | 25.56 Mn | - | - |